Arrowhead Pharmaceuticals (NASDAQ:ARWR) Given “Buy” Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. HC Wainwright currently has a $80.00 target price on the biotechnology company’s stock. Other research analysts also recently issued reports about the stock. Piper Sandler lowered their price objective […]
HC Wainwright reissued their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. HC Wainwright currently has a $80.00 target price on the biotechnology company’s stock. Other research analysts also recently issued reports about the stock. Piper Sandler lowered their price objective […]
